IXC 0.00% 8.0¢ invex therapeutics ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 795 Posts.
    lightbulb Created with Sketch. 45
    As others have said I think the fact that we are already approved for one trial in EMA with a drug with very strong phase 2 results makes this a very easy play, once market realises these two points I would be surprised if we didnt hit between 200-300 mil during phase 3 trials, IMO DYOR

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.